Geron Corp. (GERN)
1.23
+0.04
(+3.36%)
USD |
NASDAQ |
Oct 15, 16:00
1.22
-0.01
(-0.81%)
After-Hours: 20:00
Geron Cash from Operations (TTM) : -114.38M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -114.38M |
| March 31, 2026 | -125.96M |
| December 31, 2025 | -111.04M |
| September 30, 2025 | -132.92M |
| June 30, 2025 | -178.28M |
| March 31, 2025 | -204.34M |
| December 31, 2024 | -218.62M |
| September 30, 2024 | -215.61M |
| June 30, 2024 | -207.51M |
| March 31, 2024 | -183.63M |
| December 31, 2023 | -167.74M |
| September 30, 2023 | -161.99M |
| June 30, 2023 | -140.73M |
| March 31, 2023 | -139.77M |
| December 31, 2022 | -127.38M |
| September 30, 2022 | -114.37M |
| June 30, 2022 | -107.62M |
| March 31, 2022 | -96.80M |
| December 31, 2021 | -95.56M |
| September 30, 2021 | -86.00M |
| June 30, 2021 | -78.61M |
| March 31, 2021 | -73.19M |
| December 31, 2020 | -66.65M |
| September 30, 2020 | -64.40M |
| June 30, 2020 | -60.94M |
| Date | Value |
|---|---|
| March 31, 2020 | -57.28M |
| December 31, 2019 | -43.83M |
| September 30, 2019 | -36.47M |
| June 30, 2019 | -30.63M |
| March 31, 2019 | -26.38M |
| December 31, 2018 | -21.01M |
| September 30, 2018 | -22.39M |
| June 30, 2018 | -20.67M |
| March 31, 2018 | -20.62M |
| December 31, 2017 | -20.56M |
| September 30, 2017 | -16.77M |
| June 30, 2017 | -18.90M |
| March 31, 2017 | -20.10M |
| December 31, 2016 | -18.37M |
| September 30, 2016 | -23.02M |
| June 30, 2016 | -21.37M |
| March 31, 2016 | -22.07M |
| December 31, 2015 | -24.20M |
| September 30, 2015 | 9.532M |
| June 30, 2015 | 9.965M |
| March 31, 2015 | 11.15M |
| December 31, 2014 | 9.35M |
| September 30, 2014 | -25.93M |
| June 30, 2014 | -27.18M |
| March 31, 2014 | -29.96M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Precigen, Inc. | -114.16M |
| Editas Medicine, Inc. | -119.86M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 12.48B |
| Anika Therapeutics, Inc. | 5.977M |